The Federal Trade Commission (FTC) released a report suggesting that pharmaceutical firms producing brand name drugs may have engaged in anticompetitive patent dispute settlements, leading to higher drug prices for consumers last year.The Government Accountability Office (GAO) released a study revealing that agencies often fail to provide notice of proposed rules, rendering those rules unavailable for public comment.The Beijing Municipal Environmental Protection Bureau (BJEPB) invited public… [read post]